News

Analysts Update Snowflake Price Targets After Impressive Q3

Analysts Update Snowflake Price Targets After Impressive Q3

Snowflake's Impressive Earnings and Analyst Response

Snowflake Inc (NYSE: SNOW) has showcased an impressive financial performance recently, surprising analysts with its results. The company reported a remarkable third-quarter revenue of $1.21 billion, which exceeded the market's expectations.

Strong Revenue Growth

Analysts had predicted Snowflake's revenue to reach $1.18 billion, making the actual results a significant win for the company. This level of performance signals strong growth within the AI data cloud sector, which is becoming essential for businesses operating in a data-driven landscape.

Insights from Leadership

Sridhar Ramaswamy, CEO of Snowflake, emphasized the critical role the company plays in enabling its customers' data and AI strategies. He stated, "Snowflake Intelligence, our enterprise AI agent, saw the fastest adoption ramp in Snowflake history, transforming how businesses interact with their data by delivering real-time, actionable intelligence." This highlights Snowflake's commitment to innovation and customer satisfaction.

Future Expectations

Looking forward, Snowflake anticipates fourth-quarter product revenue to range between $1.195 billion and $1.20 billion, indicating an approximate 27% year-over-year growth. However, the company has adjusted its outlook for operating margins, expecting a drop from 11% in the third quarter to 7% in the upcoming quarter. This shift may have influenced the stock's performance in after-hours trading.

Market Reaction

As a result of these announcements, Snowflake’s stock saw a decline of 11.2%, falling to $235.20. Despite this, analysts remain optimistic about the company's long-term prospects.

Analysts Reevaluating Price Targets

Post-earnings, several analysts made adjustments to their price targets for Snowflake:

  • Keybanc analyst Eric Heath maintained an Overweight rating and raised the price target from $275 to $285.
  • Baird analyst William Power also kept an Outperform rating while increasing the target from $260 to $270.
  • Cantor Fitzgerald’s Thomas Blakey maintained an Overweight rating and adjusted the price target from $275 to $278.
  • Morgan Stanley’s Sanjit Singh upheld the Overweight rating and raised the target from $272 to $299.
  • Wells Fargo analyst Ryan Macwilliams also supported the Overweight rating, lifting the target from $275 to $290.
  • Scotiabank's Patrick Colville maintained a Sector Outperform rating with a price target increase from $280 to $290.
  • Canaccord Genuity analyst Kingsley Crane maintained a Buy rating and raised the target from $260 to $270.
  • Stifel analyst Brad Reback upheld a Buy rating and revised the target from $260 to $280.

Considerations for Potential Investors

For investors considering Snowflake (SNOW), it's clear that analysts have a positive outlook on the company's performance despite the recent market reactions. The consensus from major financial firms indicates valuable upward adjustments, reflecting confidence in Snowflake's innovative strategies and growth potential. Such insights can assist potential buyers in making informed decisions in the stock market.

Frequently Asked Questions

What were Snowflake's latest earnings results?

Snowflake reported a revenue of $1.21 billion for the third quarter, surpassing analyst estimates.

What does the future hold for Snowflake?

Snowflake anticipates fourth-quarter revenue growth of approximately 27% year-over-year, despite adjusting its operating margin expectations.

How have analysts reacted to Snowflake's performance?

Analysts have raised their price targets following the earnings announcement, indicating strong continued support for the stock.

What was the market reaction to Snowflake's latest results?

After the earnings announcement, Snowflake's stock fell by 11.2%, trading at $235.20.

How does Snowflake's AI strategy influence its performance?

The company's focus on AI and data strategies plays a pivotal role in driving innovation and customer engagement, contributing to its revenue growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

Updated Category News Views 24

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Continue Reading
Blokees Unveils 90+ New Wonders at Shanghai Fest

Updated Category News Views 17

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Continue Reading
Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Updated Category News Views 20

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Continue Reading
SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Updated Category News Views 16

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Continue Reading
Lawsuit Highlights Inaction in School Bus Tragedy

Updated Category News Views 20

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

Continue Reading
Black Culture Icon: Plastic-Covered Couch Takes Stage

Updated Category News Views 27

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Continue Reading
Monster Energy Dominates Skateboard Podium at SLS Paris

Updated Category News Views 20

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Continue Reading
Monteverde Probes Four Key M&A Deals for Fairness

Updated Category News Views 37

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

Continue Reading
Power Knot MEA Wins THE BIZZ 2026 for Excellence

Updated Category News Views 22

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Continue Reading
Class Action Alerts: M&A Under Scrutiny

Updated Category News Views 24

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Continue Reading

Top 5 Most Recently Viewed Articles

Schall Law Firm Initiates Investigation for Pactiv Evergreen Inc.

Updated Category News Views 142

Schall Law Firm Initiates Investigation for Pactiv Evergreen Inc. The Schall Law Firm, known for advocating shareholder rights, has unveiled plans to investigate Pactiv Evergreen Inc. concerning their fiduciary responsibilities. The focus is centered on whether members of the board and the management team acted in the best interests of shareholders. This inquiry is...

Continue Reading
RAVEL Launches Enhanced AI Software for Seamless Deployment

Updated Category News Views 351

RAVEL Innovates with AI-Orchestrate Software and Solutions RAVEL, a trailblazer in IT and workload orchestration software, has recently announced significant updates to its flagship product, RAVEL Orchestrate AI, along with the introduction of its new Supermicro Turnkey AI Workload Solution. These advances aim to facilitate and accelerate the integration of AI across...

Continue Reading
Spectral AI Lowers Warrant Prices for Enhanced Investment Appeal

Updated Category News Views 107

Introduction to Spectral AI and Its Innovative Focus Spectral AI, known for its groundbreaking approach in artificial intelligence, is dedicated to transforming medical diagnostics. This Dallas-based company is on a mission to enhance treatment decisions in wound care through advanced technology. Their ongoing initiatives specifically target challenges like burns and...

Continue Reading
Jackery's Explorer 1000 V2 and 240 V2: Eco-Friendly Power Solutions

Updated Category News Views 111

Jackery's Commitment to Sustainable Energy Solutions Jackery, a well-known leader in portable power solutions, has recently made significant progress in its sustainability efforts. The company’s Explorer 1000 V2 and Explorer 240 V2 products have been awarded the Amazon Climate Pledge Friendly Label, highlighting their environmentally friendly design and outstanding...

Continue Reading
Exploring IBS-C: Ardelyx's Advances in Patient Care and Research

Updated Category News Views 149

Understanding IBS-C and Its Impact on Patients Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical leader committed to developing innovative medicines, recently made headlines with the publication of a significant review article in Clinical and Experimental Gastroenterology. The article, titled "Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel...

Continue Reading